Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

This study has been completed.

Study NCT00303524 Information provided by AstraZeneca

First Received: March 16, 2006 Last Updated: December 20, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2009
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)